Related Experiment Video
Updated: Nov 16, 2025

07:45
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
8.2K
POLR3-Related Leukodystrophy: Exploring Potential Therapeutic Approaches
Stefanie Perrier1,2, Mackenzie A Michell-Robinson1,2, Geneviève Bernard1,2,3,4,5
1Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Frontiers in Cellular Neuroscience
|February 26, 2021
Summary
POLR3-related leukodystrophy lacks treatments. This review explores stem cell transplantation, gene replacement, and gene editing as potential therapies for this rare neurological disorder.
Area of Science:
- Neuroscience
- Genetics
- Rare Diseases
Background:
- Leukodystrophies are rare inherited CNS disorders affecting white matter.
- Hypomyelinating leukodystrophies involve abnormal myelin sheath formation.
- POLR3-related (4H) leukodystrophy is common, with no current cure.
Purpose of the Study:
- To review potential therapies for POLR3-related leukodystrophy.
- To evaluate treatments for pre-clinical and clinical translation.
- To address neurological manifestations of this condition.
Main Methods:
- Review of therapeutic approaches from other leukodystrophies and genetic diseases.
- Exploration of stem cell transplantation, gene replacement, and gene editing.
- Discussion of benefits and limitations of each approach.
Main Results:
- Potential therapeutic strategies identified for POLR3-related leukodystrophy.
- Stem cell transplantation, gene replacement, and gene editing show promise.
- Benefits and limitations of these future therapeutic directions are considered.
Conclusions:
- Further pre-clinical studies are needed to validate these therapies.
- Translational research is crucial for developing effective treatments.
- Exploring novel therapeutic avenues offers hope for POLR3-related leukodystrophy patients.
Related Concept Videos
Lysosomal Hydrolases
4.2K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
Parkinson's Disease: Treatment
743
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
743

